We’re excited to share progress from our consortium, which comprises key partners such as Janssen-Biologics, Wittenburg BV, RENOLIT Healthcare Solutions, Avantor Sciences, Thermo Fisher, Polymer Science Park, Bristol Myers Squibb, BioBTX and Netherlands Foreign Investment Agency (NFIA) on developing recycling pathways for single-use flexible plastic bags in pharmaceutical settings. Our collaborative effort is focused on sustainable end-of-life solutions for these materials, which are rich in recyclable polyethylene (PE).
Phase 1 insights have revealed that both mechanical and chemical recycling methods hold promise after the removal of single-use assemblies from the bioreactor bags. Mechanical recycling has been identified as a low CO2 impact route for creating new packaging, while chemical recycling could provide new building blocks for circular production.
The next phase aims to expand our business case, requiring more end users to join the initiative and a waste handler partner for decontamination services. This expansion is crucial for the economic viability of the recycling process and compliance with regulatory standards.
For more information or to join us, we invite you to reach out and connect with us.
